Connect with us

Hi, what are you looking for?

U.S. Politics

John Rutherford, Josh Gottheimer Will Lead the Crohn’s and Colitis Caucus on Capitol Hill

Share Story Via Text or E-Mail

This week, U.S. Reps. John Rutherford, R-Fla., and Josh Gottheimer, D-NJ, announced they would lead the Crohn’s and Colitis Caucus over the next two years.

The caucus “is dedicated to educating Congress and the American public on Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD)” and “ raise awareness, support medical research, protect patient access to care, and educate Congress and Americans on IBD.”

“As a co-chair of the Congressional Crohn’s and Colitis Caucus, I am committed to working toward solutions for those living with inflammatory bowel disease,” said Rutherford. “Through our bipartisan efforts this Congress, Representative Gottheimer and I will lead the way forward to secure research funding, raise awareness, and fight for cures. Thank you to the thousands of IBD advocates across the country working alongside us and furthering our goals.”

“I’m honored to be joining with my colleague Congressman John Rutherford to co-chair the bipartisan Congressional Crohn’s and Colitis Caucus,” said Gottheimer. “We’re going to be bringing both Democrats and Republicans together to boost cutting-edge research, to help find treatments and cures, and to improve the quality of life of those impacted by these diseases.”

“The Congressional Crohn’s and Colitis Caucus receives support from The Crohn’s & Colitis Foundation, a volunteer-driven organization dedicated to finding cures for Crohn’s disease and ulcerative colitis and improving the quality of life of children and adults affected by these diseases,” Rutherford’s office noted.

Author

  • Kevin Derby

    Originally from Jacksonville, Kevin Derby is a contributing writer for Florida Daily and covers politics across Florida.

    View all posts

Share Story Via Text or E-Mail
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Follow our Facebook Page

Follow us on X, Insta, Linkedin
<

Related Stories